144 related articles for article (PubMed ID: 8615097)
21. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
22. Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic ossification after excision.
Sodemann B; Persson PE; Nilsson OS
Arch Orthop Trauma Surg; 1990; 109(2):53-6. PubMed ID: 2107800
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Ma R; Chen GH; Zhao LJ; Zhai XC
J Orthop Surg Res; 2018 Mar; 13(1):48. PubMed ID: 29506541
[TBL] [Abstract][Full Text] [Related]
24. Effect of ibuprofen on heterotopic ossification after hip replacement.
Elmstedt E; Lindholm TS; Nilsson OS; Törnkvist H
Acta Orthop Scand; 1985 Feb; 56(1):25-7. PubMed ID: 3920862
[TBL] [Abstract][Full Text] [Related]
25. Ketorolac prophylaxis against heterotopic ossification after hip replacement.
Pritchett JW
Clin Orthop Relat Res; 1995 May; (314):162-5. PubMed ID: 7634630
[TBL] [Abstract][Full Text] [Related]
26. [Incidence of anterior intertrochanteric ossifications after total hip arthroplasty--a retrospective long-term follow-up study].
Metzner G; Lindner B; Neumann D; Dorn U
Z Orthop Unfall; 2010 Mar; 148(2):174-9. PubMed ID: 20178081
[TBL] [Abstract][Full Text] [Related]
27. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Gebuhr P; Wilbek H; Soelberg M
Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive treatment of decompression illness with a non-steroidal anti-inflammatory drug (tenoxicam) reduces compression requirement.
Bennett M; Mitchell S; Dominguez A
Undersea Hyperb Med; 2003; 30(3):195-205. PubMed ID: 14620099
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
30. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
Fingeroth RJ; Ahmed AQ
Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
[TBL] [Abstract][Full Text] [Related]
31. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
[TBL] [Abstract][Full Text] [Related]
32. Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial.
Beckmann JT; Wylie JD; Potter MQ; Maak TG; Greene TH; Aoki SK
J Bone Joint Surg Am; 2015 Dec; 97(24):2032-7. PubMed ID: 26677237
[TBL] [Abstract][Full Text] [Related]
33. Heterotopic ossification in patients after total hip replacement.
Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
[TBL] [Abstract][Full Text] [Related]
34. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB
J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
[TBL] [Abstract][Full Text] [Related]
35. Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients.
Seegenschmiedt MH; Martus P; Goldmann AR; Wölfel R; Keilholz L; Sauer R
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):63-73. PubMed ID: 8083130
[TBL] [Abstract][Full Text] [Related]
36. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
[TBL] [Abstract][Full Text] [Related]
37. Heterotopic bone formation after noncemented total hip arthroplasty. Location of ectopic bone and the influence of postoperative antiinflammatory treatment.
Kjaersgaard-Andersen P; Sletgård J; Gjerløff C; Lund F
Clin Orthop Relat Res; 1990 Mar; (252):156-62. PubMed ID: 2105869
[TBL] [Abstract][Full Text] [Related]
38. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
Perpignano G; Bogliolo A; Puccetti L
Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
[TBL] [Abstract][Full Text] [Related]
39. Comparison of tenoxicam by intramuscular injection or wound infiltration for analgesia after inguinal herniorrhaphy.
Mikkelsen SS; Knudsen KE; Kristensen BB; Linnemann MU; Friis E; Dahl JB
Anesth Analg; 1996 Dec; 83(6):1239-43. PubMed ID: 8942593
[TBL] [Abstract][Full Text] [Related]
40. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty.
Thomas BJ; Amstutz HC
J Bone Joint Surg Am; 1985 Mar; 67(3):400-3. PubMed ID: 3919028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
